Product NDC: | 0713-0135 |
Proprietary Name: | Prochlorperazine |
Non Proprietary Name: | Prochlorperazine |
Active Ingredient(s): | 25 mg/1 & nbsp; Prochlorperazine |
Administration Route(s): | RECTAL |
Dosage Form(s): | SUPPOSITORY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0713-0135 |
Labeler Name: | G & W LABORATORIES, INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040058 |
Marketing Category: | ANDA |
Start Marketing Date: | 19931130 |
Package NDC: | 0713-0135-10 |
Package Description: | 1000 SUPPOSITORY in 1 PACKAGE (0713-0135-10) |
NDC Code | 0713-0135-10 |
Proprietary Name | Prochlorperazine |
Package Description | 1000 SUPPOSITORY in 1 PACKAGE (0713-0135-10) |
Product NDC | 0713-0135 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Prochlorperazine |
Dosage Form Name | SUPPOSITORY |
Route Name | RECTAL |
Start Marketing Date | 19931130 |
Marketing Category Name | ANDA |
Labeler Name | G & W LABORATORIES, INC. |
Substance Name | PROCHLORPERAZINE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |